Miss Joan Grieve

Miss Joan GrieveTel: 0203 448 3305
Fax: 0203 448 3340
Email: joan.grieve@nhs.net

National Hospital for Neurology and Neurosurgery

Brain Tumour Service (Neuro-Oncology), Neurosurgery, Stereotactic radiosurgery services

Professional background

Miss Grieve completed her undergraduate medical studies at George’s Hospital Medical School in 1990. The majority of her neurosurgical training was undertaken at Atkinson Morley’s Hospital in Wimbledon, although she also spent time at the National Hospital for Neurology and Neurosurgery and Great Ormond Street Hospital for Children. She successfully passed FRCS(SN) in 2000 and was appointed consultant neurosurgeon at the National Hospital for Neurology and Neurosurgery (NHNN) in 2002.

During her training Miss Grieve undertook research at the NHNN and was awarded her MD thesis entitled ‘Novel imaging techniques in brain arteriovenous malformations’ by the University of London in 2004.

Her clinical interests include pituitary and parasellar pathologies; neurovascular treatment for intracranial aneurysms, arteriovenous malformations and cavernous haemangiomas; gamma knife radiosurgery; and neuro-oncology as well as general intracranial neurosurgery.

The National Neurosurgical Audit Programme (NNAP), administered by the Society of British Neurological Surgeons (SBNS), has shown that between 2013-2015, Miss Grieve personally undertook 9% (305 operations out of a total 3300) of the total number of pituitary procedures and that as a unit provided care to 14% of the total number of pituitary patients nationally. 

Miss Grieve was clinical lead for neurosurgery from 2007-2013, managing the department of neurosurgery at that time comprising of 18 surgeons, including 14 neurosurgeons, two orthopaedic surgeons and two ENT surgeons. During her tenure, she oversaw the amalgamation of neurosurgical services for North Central London (then based at the NHNN and Royal Free Hospitals) into a single service at the NHNN. She also oversaw the opening of the first nationally dedicated brain tumour ward, Molly Lane Fox Brain Tumour Unit; and the provision of a single site pituitary and skull base neurosurgical service for North London at Queen Square.

She is a member of the Society of British Neurosurgeons, the British Neurovascular Group and an international member of the Congress of Neurological Surgeons.

Research interests

  • Pituitary
  • Parasellar pathology
  • Neuro-oncology
  • Gamma knife radiosurgery
  • Vascular neurosurgery
  • General neurosurgery.


  1. Heterogenous genetic background of the association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results from a large patient cohort.
    J Denes , F Swords, E Rattenbury, K Stals et al.
    J Clin Endocrinol Metab. 2014;100(3). 
  2. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    EA Garcia, G Trivellin, ED Aflorei, M Powell, J Grieve, G Alusi, L Pobereskin, B Shariati, S Cudlip, F Roncaroli, N Mendoza, AB Grossman, EA Harper, M Korbonits.
    J Clin Endocrinol Metab. 2013; 98(12):E1918-26.
  3. Early single centre experience of flow diverting stents for the treatment of cerebral aneurysms.
    AK Toma, F Robertson, K Wong, Y Joshi, A Haridas, J Grieve, LD Watkins, ND Kitchen, S Brew.
    Br J Neurosurg 2013; 27(5):622-8.
  4. Angiogram negative subarachnoid haemorrhage: outcomes and the role of repeat angiography.
    AA Khan, JD Smith, MA Kirkman, FJ Robertson, K Wong, C Dott, JP Grieve, LD Watkins, ND Kitchen.
    Clin Neurol Neurosurg 2013; 115(8):1470-5.  
  5. Epigenetic regulation of survivin by Bmi1 is cell type specific during corticogenesis and in gliomas.
    S Acquati, A Greco, D Licastro, H Bhagat, D Ceric, Z Rossini, J Grieve, M Shaked-Rabi, NV Henriquez, S Brandner, E Stupka, S Marino.
    Stem Cells 2013; 31(1):190-202.
  6. Diagnostic implications of histological analysis of neurosurgical aspirate in addition to routine resections.G Zadeh, F Salehi, S An, C Uff, S Camp, T Revesz, J Holton, M Thom, AW McEvoy, J Grieve, N Kitchen, S Brandner.
    Neuropathology 2012; 32(1):44-50.
  7. Outcome in poor grade subarachnoid haemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive care.
    Taylor CJ, Roberston F, Brealey D, O'Shea F, Stephen T, Brew S, Grieve JP, Smith M, Appleby I.
    Neurocritical Care 2011; 14(3): 341-7.
  8. Stability of ruptured intracranial aneurysms treated with detachable coils: is delayed follow-up angiography warranted?
    Tailor J, Goetz P, Chandrashekar H, Stephen T, Schiariti M, Grieve J, Watkins L, Brew S, Robertson F, Kitchen N.
    British Journal of Neurosurgery 2010; 24(4): 405-9
  9. Brain biopsy in dementia: clinical indications and diagnostic approach 
    Schott JM, Reiniger L, Thom M, Holton JL, Grieve J, Brandner S, Warren JD, Revesz T
    Acta Neuropathologica 2010; 120(3): 327-41.
  10. Adjustable shunt valve- induced magnetic resonance imaging artifact: a comparative study
    Toma AK, Tarnaris A, Grieve JP, Watkins LD, Kitchen ND
    Journal of Neurosurgery 2010; 113(1): 74-8.
  11. External ventricular drain insertion accuracy: is there a need for change in practice?
    Toma AK, Camp S, Watkins LD, Grieve JP, Kitchen ND
    Neurosurgery 2009; 65(6); 1197-1200; discussion 1200-1.

GMC/GDC number: 3471861